entertainment -WSS

entertainment

author：comprehensive 2025-10-02 21:04:40 - browse：32

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： The future of health care in the House

explore

WSS

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Listen: BridgeBio's big week & Lilly's Alzheimer's data

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Why the advice to take all your antibiotics may be wrong

Florida babysitter arrested over hot car death, authorities say

Why Marc Tessier

leisure time

entertainment

Wikipedia

How one medical school became remarkably diverse

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Anesthesiologist group: stop taking Ozempic before surgery

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Bright Health sells Medicare Advantage business to Molina

EMA weighs against approval for Mirati's lung cancer drug

23andMe had bad news about my health. I wish a person had delivered it

Chemotherapy drug shortage eases slightly but still widespread

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

entertainment

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

FDA panel signals lack of confidence in Amgen cancer drug data

FDA panel signals lack of confidence in Amgen cancer drug data

Prosecutors say FTX founder Sam Bankman

New chief aims to remake Sanofi Genzyme

AI can decode, harness the power of the humane immune system

explore

entertainment

knowledge

explore